Evidence map›Paper›PMID 28475856›Full record

ArticleAmerican journal of human genetics2017

International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases.

Kym M Boycott, Ana Rath, Jessica X Chong, Taila Hartley, Fowzan S Alkuraya, Gareth Baynam, Anthony J Brookes, Michael Brudno, Angel Carracedo, Johan T den Dunnen and 30 more

Abstract read
In one paragraph

Article in American journal of human genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 231 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
231citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

231 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

171 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Kym M BoycottChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada. Electronic address: kboycott@cheo.on.ca.
Ana RathOrphanet, Institut National de la Santé et de la Recherche Médicale US14, 75014 Paris, France.
Jessica X ChongDepartment of Pediatrics, University of Washington, Seattle, WA 98195, USA.
Taila HartleyChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
Fowzan S AlkurayaDepartment of Genetics, King Faisal Research Center, Riyadh 11211, Saudi Arabia; Saudi Human Genome Program, King Abdulaziz City for Science and Technology, Riyadh 11442, Saudi Arabia.
Gareth BaynamGenetic Services of Western Australia, Perth, WA 6008, Australia.
Anthony J BrookesDepartment of Genetics, University of Leicester, Leicester LE1 7RH, UK.
Michael BrudnoDepartment of Computer Science, University of Toronto, Toronto M5S 1A1, Canada.
Angel CarracedoGenomic Medicine Group, Galician Foundation of Genomic Medicine and University of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
Johan T den DunnenDepartments of Human Genetics and Clinical Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands.
Stephanie O M DykeCentre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC H3A 1A4, Canada.
Xavier EstivillExperimental Division, Sidra Medical and Research Center, PO Box 26999, Doha, Qatar; Genetics Unit, Dexeus Woman's Health, 08028 Barcelona, Spain.
Jack GoldblattGenetic Services of Western Australia, Perth, WA 6008, Australia.
Catherine GonthierOrphanet, Institut National de la Santé et de la Recherche Médicale US14, 75014 Paris, France.
Stephen C GroftNational Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892-4874, USA.
Ivo GutCentre Nacional d'Anàlisi Genòmica, Center for Genomic Regulation, Barcelona Institute of Science and Technology, Universitat Pompeu Fabra, 08028 Barcelona, Spain.
Ada HamoshMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21286, USA.
Philip HieterMichael Smith Laboratories, Department of Medical Genetics, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Sophie HöhnOrphanet, Institut National de la Santé et de la Recherche Médicale US14, 75014 Paris, France.
Matthew E HurlesWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK.
Petra KaufmannOffice of Rare Diseases Research, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892-4874, USA.
Bartha M KnoppersCentre of Genomics and Policy, Department of Human Genetics, Faculty of Medicine, McGill University, Montreal, QC H3A 1A4, Canada.
Jeffrey P KrischerUniversity of South Florida Health Informatics Institute, Tampa, FL 33620, USA.
Milan MacekDepartment of Biology and Medical Genetics, Second Faculty of Medicine, Charles University and University Hospital Motol, 150 06 Prague 5, Czech Republic.
Gert MatthijsCenter for Human Genetics, University of Leuven, 3000 Leuven, Belgium.
Annie OlryOrphanet, Institut National de la Santé et de la Recherche Médicale US14, 75014 Paris, France.
Samantha ParkerLysogene, 92 200 Neuilly-sur-Seine, France.
Justin PaschallWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK.
Anthony A PhilippakisBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Heidi L RehmBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Peter N RobinsonInstitut für Medizinische Genetik und Humangenetik, Charité Universitätsmdizin Berlin, 13353 Berlin, Germany; Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA.
Pak-Chung ShamCentre for Genomic Sciences, University of Hong Kong, Hong Kong, China.
Rumen StefanovDepartment of Social Medicine and Public Health, Faculty of Public Health, Medical University of Plovdiv, Plovdiv 4002, Bulgaria.
Domenica TaruscioNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome 299-00161, Italy.
Divya UnniOrphanet, Institut National de la Santé et de la Recherche Médicale US14, 75014 Paris, France.
Megan R VanstoneChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
Feng ZhangWuXi AppTec, Waigaoqiao Free Trade Zone, Shanghai 200131, China; WuXi NextCODE, Cambridge, MA 02142, USA.
Han BrunnerDepartment of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, the Netherlands; Maastricht University Medical Center, Department of Clinical Genetics, 6229 GT Maastricht, the Netherlands.
Michael J BamshadDepartment of Pediatrics, University of Washington, Seattle, WA 98195, USA; Division of Genetic Medicine, Seattle Children's Hospital, Seattle, WA 98105, USA.
Hanns LochmüllerJohn Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK.

Funding

UW Center for Mendelian GenomicsU54HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, NICKERSON, DEBORAH A · 2012 to 2015
$20.0M
Resource ProjectU41HG006627 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI HAMOSH, ADA · 2012 to 2021
$18.0M
Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
Baylor-Johns Hopkins Center for Mendelian GeneticsU54HG006542 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2012 to 2015
$15.6M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
NHGRI NIH HHS U41 HG006627NHGRI NIH HHS U54 HG006493NHGRI NIH HHS U54 HG006542NHGRI NIH HHS UM1 HG006493NHGRI NIH HHS UM1 HG008900Wellcome Trust
6 · The paper itself

Abstract

Provision of a molecularly confirmed diagnosis in a timely manner for children and adults with rare genetic diseases shortens their "diagnostic odyssey," improves disease management, and fosters genetic counseling with respect to recurrence risks while assuring reproductive choices. In a general clinical genetics setting, the current diagnostic rate is approximately 50%, but for those who do not receive a molecular diagnosis after the initial genetics evaluation, that rate is much lower. Diagnostic success for these more challenging affected individuals depends to a large extent on progress in the discovery of genes associated with, and mechanisms underlying, rare diseases. Thus, continued research is required for moving toward a more complete catalog of disease-related genes and variants. The International Rare Diseases Research Consortium (IRDiRC) was established in 2011 to bring together researchers and organizations invested in rare disease research to develop a means of achieving molecular diagnosis for all rare diseases. Here, we review the current and future bottlenecks to gene discovery and suggest strategies for enabling progress in this regard. Each successful discovery will define potential diagnostic, preventive, and therapeutic opportunities for the corresponding rare disease, enabling precision medicine for this patient population.

Indexed as

International CooperationDatabases, FactualExomeGenome, HumanHumansRare Diseasesdisease modelinggene discoverygenome sequencingIRDiRCMatchmaker Exchangeontologiesrare diseasessolving the unsolvedtranscriptome sequencing

Identifiers

PMID28475856
PMCPMC5420351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.